摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-氟苯基)-2-吡咯烷酮 | 54660-08-1

中文名称
1-(4-氟苯基)-2-吡咯烷酮
中文别名
1-(4-氟苯基)吡咯烷-2-酮
英文名称
1-(4-fluorophenyl)pyrrolidin-2-one
英文别名
——
1-(4-氟苯基)-2-吡咯烷酮化学式
CAS
54660-08-1
化学式
C10H10FNO
mdl
MFCD00138504
分子量
179.194
InChiKey
SZZJBOHBVUOQFP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    55-58 °C
  • 密度:
    1.1545 (estimate)
  • 稳定性/保质期:
    遵照规定使用和储存,则不会发生分解。

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    20.3
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S24/25
  • 海关编码:
    2933790090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    存于阴凉干燥处

SDS

SDS:b6fa23592ecb288e1590ab0ec713aac3
查看
Name: 1-(4-Fluorophenyl)-2-pyrrolidinone 99+% Material Safety Data Sheet
Synonym: None
CAS: 54660-08-1
Section 1 - Chemical Product MSDS Name:1-(4-Fluorophenyl)-2-pyrrolidinone 99+% Material Safety Data Sheet
Synonym:None

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
54660-08-1 1-(4-Fluorophenyl)-2-pyrrolidinone >99 unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. May be harmful if inhaled.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up, then place into a suitable container for disposal. Avoid generating dusty conditions. Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid breathing dust.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 54660-08-1: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: beige
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 55 - 58 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H10FNO
Molecular Weight: 179.19

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 54660-08-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-(4-Fluorophenyl)-2-pyrrolidinone - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 54660-08-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 54660-08-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 54660-08-1 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(4-氟苯基)-2-吡咯烷酮 在 C37H46FeN4二苯基硅烷 作用下, 以 四氢呋喃 为溶剂, 反应 24.0h, 以91%的产率得到1-(4-fluorophenyl)pyrrolidine
    参考文献:
    名称:
    双-N-杂环卡宾 (NHC) 稳定的 η6-Arene Iron(0) 配合物:合成、结构、反应性和催化活性
    摘要:
    FeCl2 与螯合双-N-杂环卡宾 (NHC) 双-(N-Dipp-imidazole-2-ylidene) 亚甲基(缩写为 {((Dipp)C:)2CH2})(Dipp = 2,6-di -异丙基苯基)以高产率提供复合物 [FeCl2{((Dipp)C:)2CH2}] (1)。用过量的 KC8 还原配合物 1 和 10 倍摩尔过量的 PMe3,得到 Fe(II) 配合物 [FeH{((Dipp)C:)2CH2}(PMe3)(η(2)-PMe2CH2)] (2)作为三种立体异构体的混合物。配合物 2 是第一个带有 NHC 和 PMe3 配体的铁 (II) 配合物的第一个例子,很可能是从原位还原生成的 16 VE Fe(0) 配合物,[Fe{((Dipp)C:)2CH2 }(PMe3)2] (2'),在磷结合的 CH3 基团之一的分子内 CH 活化之后。配合物 2 在芳香族溶剂中不稳定并形成,通过涉及分子内还原消除和伴随的
    DOI:
    10.1021/ja410234x
  • 作为产物:
    描述:
    1-(4-fluorophenyl)piperidine 在 oxone||potassium monopersulfate triple salt 、 氧气 、 copper diacetate 作用下, 以 乙腈 为溶剂, 80.0 ℃ 、101.33 kPa 条件下, 反应 12.0h, 以59%的产率得到1-(4-氟苯基)-2-吡咯烷酮
    参考文献:
    名称:
    通过哌啶衍生物的环收缩和甲酰基化官能化选择性合成吡咯烷酮-2-酮和3-碘吡咯
    摘要:
    在本文中,提出了通过N-取代的哌啶的级联反应选择性合成吡咯烷酮-2-酮和3-碘吡咯的方法。从机理上讲,吡咯烷-2-酮的形成涉及一个多米诺过程,包括原位形成吡咯烷-2-甲醛,然后形成羧酸,脱羧和ipso-氧化。另一方面,据信3-碘吡咯是通过首先生成吡咯烷-2-甲醛,然后形成羧酸,脱羧,脱氢,碘化和芳构化。有趣的是,可以从相同的底物选择性地获得吡咯烷-2-酮或3-碘吡咯,并且可以通过使用特定的氧化剂和添加剂容易地调节选择性。
    DOI:
    10.1039/c8ob02640h
点击查看最新优质反应信息

文献信息

  • Rhodium(III)-Catalyzed C-H Vinylation of Arenes: Access to Functionalized Styrenes
    作者:Jun Zhou、Xin Li、Gang Liao、Bing-Feng Shi
    DOI:10.1002/cjoc.201800354
    日期:2018.12
    An effective method has been developed for Rh(III)‐catalyzed direct vinylation of arenes to give functionalized styrenes, using vinyltriethoxysilane as a convenient and inexpensive vinyl source. A wide variety of substrates, including 1‐aryl‐2‐pyrrolidinones, anilines, benzamides and ketones, were compatible with this reaction. Moreover, this method can be applied to the two‐step synthesis of functionalized
    已开发出一种有效的方法,可使用乙烯基三乙氧基硅烷作为方便,廉价的乙烯基来源,对Rh(III)催化的芳烃进行直接乙烯基化,以生成官能化的苯乙烯。此反应兼容多种底物,包括1-芳基-2-吡咯烷酮,苯胺,苯甲酰胺和酮。而且,该方法可以应用于功能化吲哚的两步合成。机理研究表明该反应可能通过氧化性Heck /去甲硅烷基化途径进行。
  • Mild and Efficient Cobalt-Catalyzed Cross-Coupling of Aliphatic Amides and Aryl Iodides in Water
    作者:Yong-Chua Teo、Bryan Tan
    DOI:10.1055/s-0034-1380724
    日期:——
    convenient protocol for the C–N cross-coupling of aliphatic amides and iodobenzene is demonstrated using a simple and inexpensive Co(C2O4)·2H2O/N,N′-dimethylethylenediamine (DMEDA) catalytic system in water. Good yields of N-arylated products were isolated (up to 85%) and the protocol has been successfully applied to the synthesis of the anticancer drug, flutamide.
    使用简单且廉价的 Co(C2O4)·2H2O/N,N'-二甲基乙二胺 (DMEDA) 催化体系在水中证明了脂肪族酰胺和碘苯的 C-N 交叉偶联的便捷方案。分离出高产率的 N-芳基化产物(高达 85%),该方案已成功应用于抗癌药物氟他胺的合成。
  • 一种吡咯烷酮类化合物的合成方法
    申请人:河南师范大学
    公开号:CN109369495B
    公开(公告)日:2021-08-06
    本发明公开了一种吡咯烷酮类化合物的合成方法,属于有机合成技术领域。将饱和环状叔胺1加入溶剂中,在氧化剂:二价铜盐、过硫酸氢钾复合盐(Oxone)和氧气的混合物等和添加剂:碘单质或碘化金属盐等存在下,加热反应制得吡咯烷酮2;该方法通过饱和环状叔胺类化合物的氧化缩环、脱羰和原位氧化等串联反应合成了吡咯烷酮类化合物,具有操作简便、条件温和、底物适用范围广等优点,为吡咯烷酮类化合物的合成提供了一种经济实用且绿色环保的新方法。
  • Ruthenium-catalyzed synthesis of <i>N</i>-substituted lactams by acceptorless dehydrogenative coupling of diols with primary amines
    作者:Yanling Zheng、Xufeng Nie、Yang Long、Li Ji、Haiyan Fu、Xueli Zheng、Hua Chen、Ruixiang Li
    DOI:10.1039/c9cc06339k
    日期:——
    Herein, we report the first example of synthesis of N-substituted lactams via an acceptorless dehydrogenative coupling of diols with primary amines in one step, which was enabled by combining Ru3(CO)12 with a hybrid N-heterocyclic carbene–phosphine–phosphine ligand as the catalyst.
    在本文中,我们报道的合成的第一示例Ñ取代的内酰胺通过与伯胺二醇的acceptorless脱氢偶联在一个步骤中,将其通过钌组合启用3(CO)12与混合动力N-杂环卡宾-膦膦配体作为催化剂。
  • Iridium(<scp>iii</scp>)-catalyzed regioselective direct arylation of sp<sup>2</sup> C–H bonds with diaryliodonium salts
    作者:Pan Gao、Li Liu、Zhuangzhi Shi、Yu Yuan
    DOI:10.1039/c6ob01145d
    日期:——
    A regioselective direct arylation of arenes and olefins at the ortho position is reported. The key to the high selectivity is the appropriate choice of diaryliodonium salts as the arylating reagent in the presence of a cationic iridium(III) catalyst. The coordination of the metal with an oxygen atom or a nitrogen atom and subsequent C–H activation allows for direct arylation with coupling partners
    据报道在邻位的芳烃和烯烃的区域选择性直接芳基化。到高选择性的关键是二芳基碘盐作为阳离子铱(存在下芳基化试剂的合适的选择III)催化剂。金属与氧原子或氮原子的配位以及随后的C–H活化可实现与偶联配偶体的直接芳基化。该反应在温和的反应条件下进行,并且对包括许多卤化物官能团在内的各种官能团具有较高的耐受性。
查看更多

同类化合物

(2R,2''R)-(-)-2,2''-联吡咯烷 麦角甾-7,22-二烯-3-基亚油酸酯 马来酰亚胺霉素 马来酰亚胺基甲基-3-马来酰亚胺基丙酸酯 马来酰亚胺丙酰基-dPEG4-NHS 马来酰亚胺-酰胺-PEG6-琥珀酰亚胺酯 马来酰亚胺-酰胺-PEG24-丙酸 马来酰亚胺-酰胺-PEG12-丙酸 马来酰亚胺-四聚乙二醇-羧酸 马来酰亚胺-四聚乙二醇-丙酸叔丁酯 马来酰亚胺-六聚乙二醇-丙酸叔丁酯 马来酰亚胺-二聚乙二醇-丙酸叔丁酯 马来酰亚胺-三(乙烯乙二醇)-丙酸 马来酰亚胺-一聚乙二醇-羧酸 马来酰亚胺-一聚乙二醇-丙烯酸琥珀酰亚胺酯 马来酰亚胺-PEG3-羟基 马来酰亚胺-PEG2-胺三氟醋酸盐 马来酰亚胺-PEG2-琥珀酰亚胺酯 马来酰亚胺 频哪醇硼酸酯 顺式4-甲基吡咯烷酮-3-醇盐酸盐 顺式3,4-二氨基吡咯烷-1-羧酸叔丁酯 顺式-二甲基 1-苄基吡咯烷-3,4-二羧酸 顺式-N-[2-(2,6-二甲基-1-哌啶基)乙基]-2-氧代-4-苯基-1-吡咯烷乙酰胺 顺式-N-Boc-吡咯烷-3,4-二羧酸 顺式-5-苄基-2-叔丁氧羰基六氢吡咯并[3,4-c]吡咯 顺式-4-氧代-六氢-吡咯并[3,4-C]吡咯-2-甲酸叔丁酯 顺式-3-氟-4-羟基吡咯烷-1-羧酸叔丁酯 顺式-3-氟-4-甲基吡咯烷盐酸盐 顺式-2-甲基六氢吡咯并[3,4-c]吡咯 顺式-2,5-二甲基吡咯烷 顺式-1-苄基-3,4-吡咯烷二甲酸二乙酯 顺式-(9CI)-3,4-二乙烯-1-(三氟乙酰基)-吡咯烷 顺-八氢环戊[c]吡咯-5-酮盐酸盐 非星匹宁 阿维巴坦中间体1 阿曲生坦中间体 阿曲生坦 间甲氧基苯乙腈 铂(2+)羟基乙酸酯-吡咯烷-3-胺(1:1:1) 钾2-氧代吡咯烷-1-磺酸酯 钠1-[(9E)-9-十八碳烯酰基氧基]-2,5-二氧代-3-吡咯烷磺酸酯 金刚烷-1-基(吡咯烷-1-基)甲酮 酸-1-吡咯烷-1,4-氨基-2-甲基-1,1,1-二甲基乙基酯,(2S,4R)- 酚丙氢吡咯 试剂3-Mercaptopropanyl-N-hydroxysuccinimideester 西他利酮 血红素酸 螺虫乙酯残留代谢物Mono-Hydroxy 萘吡坦